The Impact of Muscle Aging on Longevity (Dr. Bill Evans)
Translating Aging
Are All Drugs Safe?
Ranple: If we came up with a drug to slow the progress of sargapena, that it would be so widely adopted. Ranple: The concern is that there would be some safety concerns for some small group of people. But on the other hand, the socital impact would be large, says Ranple.
Back in the host's chair this week, Bob Hughes welcomes Dr. Bill Evans, one of the world's foremost experts on muscle aging, to the podcast. Bill is adjunct professor of Human Nutrition at University of California Berkeley and an adjunct professor of medicine in the Geriatrics Program at Duke. Previously, he was vice president and head of Muscle Metabolism Discovery Performance Unit at GlaxoSmithKline and he was also president of the Muscle and Health Division at KineMed. He was also president of the Muscle and Health Division at KineMed. Earlier this year, he was recognized with a Lifetime Achievement Award at the 2022 International Conference on Frailty, and Sarcopenia Research. Today, Bill brings his vast amount of experience and expertise to the podcast to discuss how muscle aging affects longevity in older people and the relationship between muscle aging and age-related diseases.
He begins by sharing his experience in the longevity industry, particularly with muscle aging, and goes on to discuss the term ‘sarcopenia’, including what it means and how it relates to muscle degeneration. He then explains the differences between sarcopenia and cachexia, and referring to several studies, shares the meaning of frailty, the relation of walking speed with age, and the importance of the brain–muscle connection. At the conclusion of the episode, Bill discusses the future of muscle aging and how the longevity industry hopes to find solutions that will improve the lives of people on a global scale.
Episode Highlights:
- Bill’s journey in the muscle aging industry
- Why muscle degeneration?
- The origin of the term ‘sarcopenia’
- The differences between sarcopenia and cachexia
- Is sarcopenia due to dysregulation of neuronal inputs?
- The contribution of fast-twitch and slow-twitch muscle fibers in aging
- Sarcopenia and age-related diseases
- What is frailty?
- Why our walking speed slows down as we age
- The relation between exercise and psychological state
- The brain-muscle connection
- The future of the longevity industry from Bill’s viewpoint
Quotes:
“What are some of the causes of late life disability? How does muscle change as we grow older? Why do we lose muscle?”
“A large percentage of women in particular over the age of 60 reported that they couldn't even lift 10 pounds. And the muscle weakness progressed as they grew older.”
“The primary deficit and functional deficit as we grow older is loss of strength. And that is directly related to how much muscle we have.”
“Cachexia is associated with a rapid increase in the breakdown of muscle, while sarcopenia is associated with a more gradual decrease in the rate of synthesis of muscle.”
“People generally over the age of 75, have circulating markers of inflammation.”
“People with type two diabetes and insulin resistance lose muscle at almost double the rate of people with normal glucose tolerance.”
“If we improve strength in an older person, their spontaneous activity goes up. And their habitual walking speed goes up as well.”
Links:
Email questions, comments, and feedback to podcast@bioagelabs.com
Translating Aging on Twitter: @bioagepodcast
BIOAGE Labs Website BIOAGELabs.com
BIOAGE Labs Twitter @bioagelabs
BIOAGE Labs LinkedIn
The AI-powered Podcast Player
